The present study demonstrates that rabbit aortic intimal smooth muscle cells contain the majority of their endogenous arachidonic acid mass in plasmenylethanolamine molecular species. To demonstrate the potential significance of these plasmenylethanolamines as substrates for the smooth muscle cell phospholipases that are activated during agonist stimulation, aortic rings were prelabeled with [3H]arachidonic acid and stimulated with angiotensin II. Although the specific activities of the choline and inositol glycerophospholipid pools were similar after the labeling interval, ethanolamine glycerophospholipids had a specific activity of only 20% of the specific activity of choline and inositol glycerophospholipids. Despite the marked disparity in the specific activities of these three phospholipid classes, angiotensin II stimulation resulted in similar fractional losses (35-41%) of [3lljarachidonic acid from vascular smooth muscle choline, ethanolamine, and inositol glycerophospholipid classes. Reverse-phase HPLC demonstrated that >60% of the [3H]arachidonic acid released from ethanolamine glycerophospholipids after angiotensin II stimulation originated from plasmenylethanolamine molecular species. Taken together, the results demonstrate that the major phospholipid storage depot for arachidonic acid in vascular smooth muscle cells are plasmenylethanolamine molecular species which are important substrates for the phospholipase(s) that are activated during agonist stimulation.
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Icosanoids are important regulators of vascular smooth muscle cell contractile state, hypertrophy, and proliferation (1) (2) (3) (4) (5) (6) . Accordingly, significant attention has focused on the biochemical events responsible for the liberation of arachidonic acid from endogenous smooth muscle cell lipids during signal transduction. Arachidonic acid release from cellular phospholipids may occur directly in a single catalytic step by the action of phospholipase A2 or by a multistep sequential pathway initiated by phospholipase C and culminated by the sequential actions of diglyceride and monoglyceride lipases (7) (8) (9) . Although recent studies demonstrated that radiolabeled arachidonic acid was released from choline, ethanolamine, and inositol glycerophospholipid in cultured smooth muscle cell pools after agonist stimulation, quantification of the amount of released radiolabeled arachidonic acid from each pool suggested that different phospholipid classes were primarily responsible for radiolabeled arachidonic acid release (10) (11) (12) (13) . Since the biochemical and physiologic properties of cultured smooth muscle cells differ substantially from properties of vascular smooth muscle cells in intact tissue, the present study was performed to assess the distribution of arachidonic acid mass in phospholipids and the fractional turnover of individual phospholipid molecular species in intact vascular smooth muscle. The results demonstrate that the majority of arachidonic acid mass in vascular smooth muscle is present in plasmenylethanolamine molecular species and that substantial amounts of arachidonic acid in smooth muscle plasmenylethanolamines are rapidly mobilized after angiotensin II stimulation. (Fig. 1A) . The major UV-absorbing peaks eluted at 58, 63, and 95 min, which correspond to plasmalogen molecular species with arachidonic acid at the sn-2 position and palmitic, oleic, and stearic vinyl ethers at the sn-i position (identified by comparisons with authentic standards). Another UV-absorbing peak was present at 80 min, corresponding to a diacyl phospholipid molecular species with arachidonic acid at the sn-2 position and stearic acid at the sn-i position.
MATERIALS AND METHODS
Although the integrated UV absorbances do not quantitatively represent the mass of each molecular species, comparisons between different subclasses containing arachidonic acid (i.e., peaks 1, 2, and 5 for plasmalogen molecular species versus peak 4 for diacyl molecular species) are approximate reflections of mass since the integrated UV absorbance is approximately proportional to the number of double bonds present in a given species (18) .
Reverse-phase HPLC analysis of choline glycerophospholipids (Fig. 1B) Choline and ethanolamine glycerophospholipids (CGP and EGP, respectively) from rabbit and canine aortic intima were purified by straight-phase HPLC, subjected to acid-catalyzed methanolysis, and analyzed by capillary gas chromatography. Products of phospholipase A2-treated CGP and EGP were separated by TLC and subjected to acid-catalyzed methanolysis. PLA2-CGP ( much radiolabeled arachidonic acid after the labeling interval. Accordingly, the specific activity of arachidonic acid in each major glycerophospholipid pool was substantially different. Choline and inositol glycerophospholipids had a specific activity -5-fold that of the specific activity of ethanolamine glycerophospholipids (Table 3) . It [3H]arachidonic acid was subsequently removed by two sequential 15-min incubations at 370C in 25 ml of modified oxygenated K-H buffer. The aortic rings were incubated for 15 min in modified K-H buffer containing either 100 nM angiotensin II (All) or vehicle (saline). Aortic lipids were extracted by the Bligh and Dyer (15) method, at which time 1 x 105 dpm of 14C]lysophosphatidylcholine was added (internal standard). Individual phospholipid classes were resolved by straight-phase HPLC and incorporated radiolabel was quantitated by liquid scintillation spectrometry. The values for radiolabel incorporated into each phospholipid pool are the means ± SEM for four separate experiments and are expressed as cpm/g (dry weight). RSA, relative specific activity (ratio of [3H]arachidonic acid cpm to nmol of arachidonylated phospholipid; the RSA of choline GPL was normalized to 1); GPL, glycerophospholipids.
*P < 0.05 for control vs. All-treated aortic rings. tp < 0.01 for control vs. All-treated aortic rings.
acid during the labeling interval and those that released
[3H]arachidonic acid after agonist stimulation, reverse-phase HPLC was used. As expected, radiolabeled arachidonic acid was predominantly incorporated into 1-palmitoyl-2-arachidonyl-GPC (75%) with smaller amounts present in 1-stearoyl-2-arachidonyl-GPC as well as other choline glycerophospholipid subclasses (data not shown). Angiotensin II stimulation resulted in comparable fractional decreases in each radiolabeled choline glycerophospholipid molecular species. Reverse-phase HPLC of radiolabeled ethanolamine glycerophospholipids demonstrated that plasmalogen molecular species contained the majority of radiolabeled arachidonic acid (70%), while smaller amounts (30%) were present in phosphatidylethanolamine molecular species (Fig. 3) (Fig. 3) . Statistically significant losses (P < 0.02; n = 3) of arachidonylated plasmenylethanolamine molecular species (peaks 3, 4, and 6) as well as arachidonylated phosphatidylethanolamine molecular species (peak 5) were observed. The fractional percentage of hydrolysis of each ethanolamine glycerophospholipid subclass was similar, demonstrating that the phospholipase(s) responsible for the release of arachidonic acid from vascular smooth muscle phospholipids during angiotensin II stimulation effectively hydrolyzes both phosphatidylethanolamine and plasmenylethanolamine substrates. 
DISCUSSION
The results of this study demonstrate that ethanolamine glycerophospholipids in aortic smooth muscle cells from both dogs and rabbits are predominantly composed of plasmalogen molecular species. Over 63% of plasmenylethanolamine molecular species in rabbit aorta contain arachidonic acid esterified to the sn-2 position as ascertained by capillary gas chromatography, fast atom bombardment mass spectrometry, and reverse-phase HPLC. Although plasmenylethanolamines are an important storage depot for arachidonic acid in other tissues such as platelets, Madin-Darby kidney cells, and endothelial cells (19) (20) (21) , the fact that plasmenylethanolamines represent the major phospholipid storage depot for arachidonic acid in vascular smooth muscle cells has previously gone unrecognized. Furthermore, the loss of arachidonic acid from plasmenylethanolamine during angiotensin II stimulation suggests an important biologic role for plasmenylethanolamine molecular species as substrates for the phospholipases that are activated during signal transduction in smooth muscle cells. Considering the potential role of icosanoids in the development of atherosclerotic plaques, smooth muscle cell hypertrophy, and smooth muscle cell injury, it seems likely that hydrolysis of arachidonylated plasmenylethanolamines may contribute to the pathophysiologic sequelae of these processes.
Since radiolabeled arachidonic acid is rapidly lost from plasmenylethanolamine molecular species within minutes of angiotensin II stimulation of rabbit aortic rings, vascular smooth muscle cells must contain phospholipases that are activated after agonist stimulation that can effectively utilize plasmenylethanolamine as substrate. However, quantitation of the relative contribution of the plasmenylethanolamine pool to arachidonic acid release in these studies, as well as those of others, requires assumptions about the relationship between radiolabeled ethanolamine glycerophospholipids and nonradiolabeled ethanolamine glycerophospholipids. If the simplifying assumption is made that the fractional turnover of radiolabeled ethanolamine glycerophospholipids is representative of the turnover of ethanolamine glycerophospholipids in vascular smooth muscle cells in general, then it seems likely that the ethanolamine glycerophospholipid pool is a substantial contributor to the release of arachidonic acid mass during signal transduction. Since significant subcellular compartmentation of radiolabeled ethanolamine glycerophospholipid molecular species into metabolically distinct compartments may occur, these extrapolations, as with extrapolations from any radiolabeling experiment with intact cells, should be interpreted cautiously.
Recently, the importance of alterations in membrane dynamics as a modulator of transmembrane ion flux has become increasingly appreciated (22) . The molecular dynamics of plasmalogen molecular species differ substantially from that of their diacyl counterparts (23) . Furthermore, the recent demonstration of plasmalogen selective phospholipases (24, 25) has suggested an important role of these moieties as substrates of the phospholipases that are activated during signal transduction. The results of the present study demonstrate that smooth muscle cells contain substantial amounts of arachidonylated plasmalogen molecular species, which likely contribute to smooth muscle cell function both through their effects on membrane dynamics and as important substrates for the phospholipases activated during angiotensin II stimulation.
